Genoway S.A. is a specialized biotechnology company that develops and markets genetically modified animal models for research purposes. Its primary function is to provide customized and innovative solutions for pharmaceutical companies, academic institutions, and governmental research bodies to facilitate drug discovery and development processes. Genoway's offerings include genetically-tailored mouse, rat, and other animal models, which are integral in understanding human diseases and testing new treatments. The company impacts several sectors, notably the pharmaceutical, healthcare, and academic research fields. By enabling precise genetic modifications, Genoway plays a critical role in the acceleration of biomedical research, ultimately contributing to the advancement of medical knowledge and therapies. Headquartered in France, Genoway is considered a key player within the biotechnology market, recognized for its technological expertise and contribution to the enhancement of scientific studies.